Hepatitis B ultrasound: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Ultrasound]] may be used as a [[screening]] tool in patients with [[chronic hepatitis]] for early detection of [[hepatic cirrhosis]]. | |||
==Ultrasound== | ==Ultrasound== | ||
The following findings may be identified: | The following findings may be identified: | ||
*Coarse [[echogenicity]] | *Coarse [[echogenicity]] | ||
Revision as of 04:04, 31 July 2014
|
Hepatitis B |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatitis B ultrasound On the Web |
|
American Roentgen Ray Society Images of Hepatitis B ultrasound |
|
Risk calculators and risk factors for Hepatitis B ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Ultrasound may be used as a screening tool in patients with chronic hepatitis for early detection of hepatic cirrhosis.
Ultrasound
The following findings may be identified:
- Coarse echogenicity
- Segmental hypertrophy with nodular appearance of liver
- Portal hypertension:
HBsAg carriers should have regular serial serum AFP determinations and ultrasound examinations (at 6 months intervals for those above 40 years). Both these tests are recommended to be repeated regularly for all HBsAg carriers with cirrhosis.[1]
